Denise Braendgaard: How Partnership is Turning Ambition Into Action
Denise Braendgaard, General Manager at Novo Nordisk Haemophilia and Haemoglobinopathies Foundation, shared Novo Nordisk Haemophilia and Haemoglobinopathies Foundation‘s post on LinkedIn, adding:
“2025 was a year of transformation
At the Novo Nordisk Haemophilia and Haemoglobinopathies Foundation, we expanded our vision and scope, doubling down on our commitment to sustainable access to care for people living with haemophilia and haemoglobinopathies in low- and middle-income countries.
This progress was made possible by our partners: Their leadership, expertise, and dedication continue to drive sustainable, locally anchored impact.
Our Year in Review 2025 captures the milestones, the momentum, and the collective impact achieved together.
I invite you to take a moment to read it and see how partnership is turning ambition into action.”
Novo Nordisk Haemophilia and Haemoglobinopathies Foundation shared a post on LinkedIn:
“The NNHF Year in Review 2025 is here!
This year we focused on ‘Fostering connections and unveiling new horizons’, and the results speak for themselves.
Thanks to our partners, volunteers and funders, we reached new communities, launched meaningful initiatives, and expanded our impact.
Swipe through for some of the highlights, then read the Full Report for stories and outcomes that inspire.”
Other posts featuring Denise Braendgaard on Hemostasis Today.”
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids
-
Apr 14, 2026, 16:56Saskia Middeldorp: Key Takeaways from the 2026 ACC/AHA Guideline on Acute PE
-
Apr 14, 2026, 16:54Chokri Ben Lamine: Extracorporeal Photopheresis for aGVHD cGVHD Post-SCT – 50 Pearls
-
Apr 14, 2026, 16:49Ahmed Magdi Omar: Key Takeaways From the Latest 2026 Guidelines on Antiplatelet Therapy in AIS